aluates Reports

$ 0.0

Automative

Global Immuno-Oncology Market Research Report 2026

Published Date: 2026-02-26

Report Code: QYRE-Auto-20U9090

Global Immuno Oncology Market Size Status and Forecast 2022

BUY CHAPTERS

Global Immuno-Oncology Market Research Report 2026

Code: QYRE-Auto-20U9090

Report

2026-02-26

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Merck& Co. Inc

Roche

Astrazeneca plc

Sanofi

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

Immuno-Oncology Market Size

The global Immuno-Oncology market was valued at US$ 65220 million in 2025 and is anticipated to reach US$ 170190 million by 2032, at a CAGR of 14.9% from 2026 to 2032.

Immuno-Oncology Market

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The industry"s leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.

This report delivers a comprehensive overview of the global Immuno-Oncology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immuno-Oncology. The Immuno-Oncology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Immuno-Oncology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Immuno-Oncology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Immuno-Oncology Market Report

Report Metric	Details
Report Name	Immuno-Oncology Market
Accounted market size in 2025	US$ 65220 million
Forecasted market size in 2032	US$ 170190 million
CAGR	14.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Immune Checkpoint Inhibitors Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy Others
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immuno-Oncology companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Immuno-Oncology Market growing?

Ans: The Immuno-Oncology Market witnessing a CAGR of 14.9% during the forecast period 2026-2032.

What is the Immuno-Oncology Market size in 2032?

Ans: The Immuno-Oncology Market size in 2032 will be US$ 170190 million.

Who are the main players in the Immuno-Oncology Market report?

Ans: The main players in the Immuno-Oncology Market are Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA

What are the Application segmentation covered in the Immuno-Oncology Market report?

Ans: The Applications covered in the Immuno-Oncology Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Immuno-Oncology Market report?

Ans: The Types covered in the Immuno-Oncology Market report are Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Cytokine-Based Immunotherapy

1.2.4 Cancer Vaccines

1.2.5 CAR-T Cell Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Immuno-Oncology Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immuno-Oncology Market Perspective (2021–2032)

2.2 Global Immuno-Oncology Growth Trends by Region

2.2.1 Global Immuno-Oncology Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Immuno-Oncology Historic Market Size by Region (2021–2026)

2.2.3 Immuno-Oncology Forecasted Market Size by Region (2027–2032)

2.3 Immuno-Oncology Market Dynamics

2.3.1 Immuno-Oncology Industry Trends

2.3.2 Immuno-Oncology Market Drivers

2.3.3 Immuno-Oncology Market Challenges

2.3.4 Immuno-Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immuno-Oncology Players by Revenue

3.1.1 Global Top Immuno-Oncology Players by Revenue (2021–2026)

3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2021–2026)

3.2 Global Top Immuno-Oncology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Immuno-Oncology Revenue

3.4 Global Immuno-Oncology Market Concentration Ratio

3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2025

3.5 Global Key Players of Immuno-Oncology Head Offices and Areas Served

3.6 Global Key Players of Immuno-Oncology, Products and Applications

3.7 Global Key Players of Immuno-Oncology, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Immuno-Oncology Breakdown Data by Type

4.1 Global Immuno-Oncology Historic Market Size by Type (2021–2026)

4.2 Global Immuno-Oncology Forecasted Market Size by Type (2027–2032)

5 Immuno-Oncology Breakdown Data by Application

5.1 Global Immuno-Oncology Historic Market Size by Application (2021–2026)

5.2 Global Immuno-Oncology Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Immuno-Oncology Market Size (2021–2032)

6.2 North America Immuno-Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Immuno-Oncology Market Size by Country (2021–2026)

6.4 North America Immuno-Oncology Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immuno-Oncology Market Size (2021–2032)

7.2 Europe Immuno-Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Immuno-Oncology Market Size by Country (2021–2026)

7.4 Europe Immuno-Oncology Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Immuno-Oncology Market Size (2021–2032)

8.2 Asia-Pacific Immuno-Oncology Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Immuno-Oncology Market Size by Region (2021–2026)

8.4 Asia-Pacific Immuno-Oncology Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Immuno-Oncology Market Size (2021–2032)

9.2 Latin America Immuno-Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Immuno-Oncology Market Size by Country (2021–2026)

9.4 Latin America Immuno-Oncology Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immuno-Oncology Market Size (2021–2032)

10.2 Middle East & Africa Immuno-Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Immuno-Oncology Market Size by Country (2021–2026)

10.4 Middle East & Africa Immuno-Oncology Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Details

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction

11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2021–2026)

11.1.5 Bristol-Myers Squibb Recent Development

11.2 Merck & Co., Inc.

11.2.1 Merck & Co., Inc. Company Details

11.2.2 Merck & Co., Inc. Business Overview

11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction

11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2021–2026)

11.2.5 Merck & Co., Inc. Recent Development

11.3 Roche AG

11.3.1 Roche AG Company Details

11.3.2 Roche AG Business Overview

11.3.3 Roche AG Immuno-Oncology Introduction

11.3.4 Roche AG Revenue in Immuno-Oncology Business (2021–2026)

11.3.5 Roche AG Recent Development

11.4 AstraZeneca, Plc

11.4.1 AstraZeneca, Plc Company Details

11.4.2 AstraZeneca, Plc Business Overview

11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction

11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2021–2026)

11.4.5 AstraZeneca, Plc Recent Development

11.5 Sanofi S.A.

11.5.1 Sanofi S.A. Company Details

11.5.2 Sanofi S.A. Business Overview

11.5.3 Sanofi S.A. Immuno-Oncology Introduction

11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2021–2026)

11.5.5 Sanofi S.A. Recent Development

11.6 Dendreon Pharmaceuticals

11.6.1 Dendreon Pharmaceuticals Company Details

11.6.2 Dendreon Pharmaceuticals Business Overview

11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction

11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2021–2026)

11.6.5 Dendreon Pharmaceuticals Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Immuno-Oncology Introduction

11.7.4 Novartis Revenue in Immuno-Oncology Business (2021–2026)

11.7.5 Novartis Recent Development

11.8 Gilead Sciences Inc.

11.8.1 Gilead Sciences Inc. Company Details

11.8.2 Gilead Sciences Inc. Business Overview

11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction

11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2021–2026)

11.8.5 Gilead Sciences Inc. Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Details

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Immuno-Oncology Introduction

11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2021–2026)

11.9.5 Merck KGaA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol–Myers Squibb

Merck& Co. Inc

Roche

Astrazeneca plc

Sanofi

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

List of Tables

Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Immune Checkpoint Inhibitors

Table 3. Key Players of Cytokine-Based Immunotherapy

Table 4. Key Players of Cancer Vaccines

Table 5. Key Players of CAR-T Cell Therapy

Table 6. Key Players of Others

Table 7. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Immuno-Oncology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Immuno-Oncology Market Size by Region (US$ Million), 2021–2026

Table 10. Global Immuno-Oncology Market Share by Region (2021–2026)

Table 11. Global Immuno-Oncology Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Immuno-Oncology Market Share by Region (2027–2032)

Table 13. Immuno-Oncology Market Trends

Table 14. Immuno-Oncology Market Drivers

Table 15. Immuno-Oncology Market Challenges

Table 16. Immuno-Oncology Market Restraints

Table 17. Global Immuno-Oncology Revenue by Players (US$ Million), 2021–2026

Table 18. Global Immuno-Oncology Market Share by Players (2021–2026)

Table 19. Global Top Immuno-Oncology Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immuno-Oncology Revenue, 2025

Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Immuno-Oncology, Headquarters and Area Served

Table 23. Global Key Players of Immuno-Oncology, Products and Applications

Table 24. Global Key Players of Immuno-Oncology, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Immuno-Oncology Market Size by Type (US$ Million), 2021–2026

Table 27. Global Immuno-Oncology Revenue Market Share by Type (2021–2026)

Table 28. Global Immuno-Oncology Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Immuno-Oncology Revenue Market Share by Type (2027–2032)

Table 30. Global Immuno-Oncology Market Size by Application (US$ Million), 2021–2026

Table 31. Global Immuno-Oncology Revenue Market Share by Application (2021–2026)

Table 32. Global Immuno-Oncology Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Immuno-Oncology Revenue Market Share by Application (2027–2032)

Table 34. North America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Immuno-Oncology Market Size by Country (US$ Million), 2021–2026

Table 36. North America Immuno-Oncology Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Immuno-Oncology Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Immuno-Oncology Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Immuno-Oncology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Immuno-Oncology Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Immuno-Oncology Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Immuno-Oncology Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Immuno-Oncology Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Immuno-Oncology Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Immuno-Oncology Market Size by Country (US$ Million), 2027–2032

Table 49. Bristol-Myers Squibb Company Details

Table 50. Bristol-Myers Squibb Business Overview

Table 51. Bristol-Myers Squibb Immuno-Oncology Product

Table 52. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 53. Bristol-Myers Squibb Recent Development

Table 54. Merck & Co., Inc. Company Details

Table 55. Merck & Co., Inc. Business Overview

Table 56. Merck & Co., Inc. Immuno-Oncology Product

Table 57. Merck & Co., Inc. Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 58. Merck & Co., Inc. Recent Development

Table 59. Roche AG Company Details

Table 60. Roche AG Business Overview

Table 61. Roche AG Immuno-Oncology Product

Table 62. Roche AG Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 63. Roche AG Recent Development

Table 64. AstraZeneca, Plc Company Details

Table 65. AstraZeneca, Plc Business Overview

Table 66. AstraZeneca, Plc Immuno-Oncology Product

Table 67. AstraZeneca, Plc Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 68. AstraZeneca, Plc Recent Development

Table 69. Sanofi S.A. Company Details

Table 70. Sanofi S.A. Business Overview

Table 71. Sanofi S.A. Immuno-Oncology Product

Table 72. Sanofi S.A. Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 73. Sanofi S.A. Recent Development

Table 74. Dendreon Pharmaceuticals Company Details

Table 75. Dendreon Pharmaceuticals Business Overview

Table 76. Dendreon Pharmaceuticals Immuno-Oncology Product

Table 77. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 78. Dendreon Pharmaceuticals Recent Development

Table 79. Novartis Company Details

Table 80. Novartis Business Overview

Table 81. Novartis Immuno-Oncology Product

Table 82. Novartis Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 83. Novartis Recent Development

Table 84. Gilead Sciences Inc. Company Details

Table 85. Gilead Sciences Inc. Business Overview

Table 86. Gilead Sciences Inc. Immuno-Oncology Product

Table 87. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 88. Gilead Sciences Inc. Recent Development

Table 89. Merck KGaA Company Details

Table 90. Merck KGaA Business Overview

Table 91. Merck KGaA Immuno-Oncology Product

Table 92. Merck KGaA Revenue in Immuno-Oncology Business (US$ Million), 2021–2026

Table 93. Merck KGaA Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

Table 97. Authors List of This Report

List of Figures

Figure 1. Immuno-Oncology Picture

Figure 2. Global Immuno-Oncology Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Immuno-Oncology Market Share by Type: 2025 vs 2032

Figure 4. Immune Checkpoint Inhibitors Features

Figure 5. Cytokine-Based Immunotherapy Features

Figure 6. Cancer Vaccines Features

Figure 7. CAR-T Cell Therapy Features

Figure 8. Others Features

Figure 9. Global Immuno-Oncology Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Immuno-Oncology Market Share by Application: 2025 vs 2032

Figure 11. Hospitals Case Studies

Figure 12. Drugstores Case Studies

Figure 13. Others Case Studies

Figure 14. Immuno-Oncology Report Years Considered

Figure 15. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Immuno-Oncology Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Immuno-Oncology Market Share by Region: 2025 vs 2032

Figure 18. Global Immuno-Oncology Market Share by Players in 2025

Figure 19. Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2025

Figure 21. North America Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Immuno-Oncology Market Share by Country (2021–2032)

Figure 23. United States Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Immuno-Oncology Market Share by Country (2021–2032)

Figure 27. Germany Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Immuno-Oncology Market Share by Region (2021–2032)

Figure 35. China Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Immuno-Oncology Market Share by Country (2021–2032)

Figure 43. Mexico Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Immuno-Oncology Market Share by Country (2021–2032)

Figure 47. Israel Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Immuno-Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 51. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 52. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 53. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 54. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 55. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 56. Novartis Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 57. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 58. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2021–2026)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oncology Immunotherapy Market

Global Immuno Oncology Service Market Research Report 2024

Global Immuno oncology Therapy Market Insights Forecast to 2030

Immuno Oncology Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno oncology Clinical Trials Market Research Report 2024

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immuno Oncology Assays Kit Market Insights Forecast to 2030

Global Immuno Oncology Treatment Market Insights Forecast to 2030

Global Immunotherapy Drugs Market Research Report 2024

AI In Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Oncology EMR Software Market Insights Forecast to 2030

Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Global Cancer Immunosuppressant Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions